{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:31:56Z","timestamp":1787002316488,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1497,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/mt.2012.114","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T09:49:10Z","timestamp":1340704150000},"page":"1713-1723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Gene Transfer to the CNS Is Efficacious in Immune-primed Mice Harboring Physiologically Relevant Titers of Anti-AAV Antibodies"],"prefix":"10.1016","volume":"20","author":[{"given":"Christopher M","family":"Treleaven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Tamsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Pablo","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D","family":"Hurlbut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A","family":"Passini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamya S","family":"Shihabuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.114_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/mthe.1999.0005","article-title":"Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors","volume":"1","author":"Bosch","year":"2000","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib2","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib3","doi-asserted-by":"crossref","first-page":"17822","DOI":"10.1073\/pnas.0509062102","article-title":"Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease","volume":"102","author":"Dodge","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.114_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2008.60","article-title":"Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity","volume":"16","author":"Dodge","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2012.114_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2012.114_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.114_bib8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2012.114_bib9","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.114_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N","article-title":"Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)","volume":"59","author":"Erles","year":"1999","journal-title":"J Med Virol"},{"key":"10.1038\/mt.2012.114_bib11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/JVI.74.3.1524-1532.2000","article-title":"Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes","volume":"74","author":"Halbert","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.114_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/hum.1998.9.4-477","article-title":"Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors","volume":"9","author":"Manning","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.114_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156652307782151498","article-title":"Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions","volume":"7","author":"Lowenstein","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2012.114_bib14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0b013e3181c29356","article-title":"Safety and tolerability of putaminal AADC gene therapy for Parkinson disease","volume":"73","author":"Christine","year":"2009","journal-title":"Neurology"},{"key":"10.1038\/mt.2012.114_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2012.114_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jgm.885","article-title":"Immune responses to AAV in a phase I study for Canavan disease","volume":"8","author":"McPhee","year":"2006","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2012.114_bib17","first-page":"240","article-title":"CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease","volume":"12","author":"Mandel","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2012.114_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.114_bib19","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/JVI.78.12.6344-6359.2004","article-title":"Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain","volume":"78","author":"Peden","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.114_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ymthe.2003.12.005","article-title":"Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV","volume":"9","author":"Sanftner","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib21","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/mt.2010.175","article-title":"Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy","volume":"18","author":"Hurlbut","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib22","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.114_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2012.114_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/hum.2006.17.440","article-title":"Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors","volume":"17","author":"Halbert","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.114_bib25","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/sj.mt.6300305","article-title":"One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications","volume":"15","author":"Barcia","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ymthe.2005.01.011","article-title":"AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease","volume":"11","author":"Passini","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/mthe.2001.0520","article-title":"Targeted retrograde gene delivery for neuronal protection","volume":"5","author":"Kaspar","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib28","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.114_bib29","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2005-08-3229","article-title":"Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice","volume":"107","author":"Scallan","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2012.114_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2012.114_bib31","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1096\/fasebj.7.13.8405808","article-title":"Astrocytes in infectious and immune-mediated diseases of the central nervous system","volume":"7","author":"Mucke","year":"1993","journal-title":"FASEB J"},{"key":"10.1038\/mt.2012.114_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1038\/mt.2012.114_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boill\u00e9e","year":"2006","journal-title":"Neuron"},{"key":"10.1038\/mt.2012.114_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.1038\/mt.2012.114_bib35","series-title":"In the Metabolic and Molecular Basis of Inherited Disease","first-page":"3589","article-title":"Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies","author":"Schuchman","year":"2001"},{"key":"10.1038\/mt.2012.114_bib36","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.0703509104","article-title":"Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse","volume":"104","author":"Passini","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.114_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exnr.1999.7176","article-title":"Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice","volume":"160","author":"Skorupa","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2012.114_bib38","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/mt.2010.206","article-title":"AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice","volume":"18","author":"Dodge","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/clim.1999.4724","article-title":"Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration","volume":"92","author":"Brockstedt","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1038\/mt.2012.114_bib40","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.gt.3302539","article-title":"Major role of local immune responses in antibody formation to factor IX in AAV gene transfer","volume":"12","author":"Wang","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.114_bib41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/gt.2010.2","article-title":"Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks","volume":"17","author":"McMenamin","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.114_bib42","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","article-title":"Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors","volume":"25","author":"Liu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2012.114_bib43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.mt.6300090","article-title":"Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes","volume":"15","author":"Li","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib44","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/mt.2010.106","article-title":"Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC","volume":"18","author":"Hadaczek","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/mt.2009.286","article-title":"Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain","volume":"18","author":"Markakis","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.114_bib46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.114_bib47","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1089\/hum.1997.8.16-1891","article-title":"Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice","volume":"8","author":"Snyder","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.114_bib48","series-title":"Mol Ther","first-page":"S324","article-title":"Efficacy of AAV-mediated expression of acid sphingomyelinase at correcting the visceral and pulmonary manifestations of Niemann-Pick B disease","author":"Barbon","year":"2004"},{"key":"10.1038\/mt.2012.114_bib49","doi-asserted-by":"crossref","first-page":"10642","DOI":"10.1523\/JNEUROSCI.3584-04.2004","article-title":"Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology","volume":"24","author":"Shihabuddin","year":"2004","journal-title":"J Neurosci"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:36:09Z","timestamp":1734539769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616321621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1525001616321621"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.114","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Transfer to the CNS Is Efficacious in Immune-primed Mice Harboring Physiologically Relevant Titers of Anti-AAV Antibodies","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2012.114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}